LBTYA 47.07 Liberty Global $LBTYA Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
LBTYA 47.07 Liberty Global $LBTYA Hit a 52 week high of 47.44 Closing the day 09:45 at 47.07 -0.33 -0.70% With a day low of 46.93 and a total volume of 232,494.

LBTYA Recent Posts: http://investorshangout.com/Liberty-Global-LBTYA-54608/

LBTYA Liberty Global Recent Headline News

Liberty Global Set to Possibly Pullback After Yesterday's Rally of 2.02%
Comtex SmarTrend(R) - Wed Nov 12, 3:54PM CST
Liberty Global (NASDAQ:LBTYA) traded in a range yesterday that spanned from a low of $46.17 to a high of $47.49. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $46.78 on volume of 5.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LBTYA: 47.50 (+0.10)

After Yesterday's Rally of 2.02% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 12, 3:53PM CST
Liberty Global (NASDAQ:LBTYA) traded in a range yesterday that spanned from a low of $46.17 to a high of $47.49. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $46.78 on volume of 5.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LBTYA: 47.50 (+0.10)

Liberty Global Q3 Earnings Beat, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:00PM CST
Liberty Global plc (LBTYA) reported mixed financial numbers for the third-quarter of 2014, wherein earnings surpassed the Zacks Consensus Estimate but revenues missed the same.
LBTYA: 47.50 (+0.10), TSQ: 12.53 (+0.21), LIN: 23.78 (+0.13), SIRI: 3.50 (+0.01)

Liberty Global (LBTYA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 7:23PM CST
The following Liberty Global (LBTYA) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
LBTYA: 47.50 (+0.10)

Liberty Global Rises 2.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Nov 06, 4:09PM CST
Liberty Global (NASDAQ:LBTYA) traded in a range yesterday that spanned from a low of $44.28 to a high of $46.04. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $46.04 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LBTYA: 47.50 (+0.10)

SmarTrend Watching for Potential Pullback in Shares of Liberty Global After 2.14% Gain
Comtex SmarTrend(R) - Thu Nov 06, 4:08PM CST
Liberty Global (NASDAQ:LBTYA) traded in a range yesterday that spanned from a low of $44.28 to a high of $46.04. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $46.04 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LBTYA: 47.50 (+0.10)

Liberty Global's (LBTYA) CEO Mike Fries on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 2:17PM CST

LBTYA: 47.50 (+0.10)

Liberty Global posts 3Q profit
Automated Insights - Thu Nov 06, 4:04AM CST
LONDON (AP) _ Liberty Global PLC (LBTYA) on Thursday reported net income of $157.1 million, or 20 cents per share, in its third quarter.
LBTYK: 46.05 (-0.18), LBTYB: 46.83 (+0.25), LBTYA: 47.50 (+0.10)

Liberty Global beats by $0.23, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:52PM CST

LBTYA: 47.50 (+0.10)

Liberty Global Reports Q3 & YTD 2014 Results
Business Wire - Wed Nov 05, 3:45PM CST
--Rebased OCF Growth of 5% in Q3 and 6% YTD
LBTYK: 46.05 (-0.18), LBTYB: 46.83 (+0.25), LBTYA: 47.50 (+0.10)

Liberty Global Completes Tender Offer for Ziggo
Business Wire - Wed Nov 05, 3:15PM CST
--Following the Offer and post-closing procedures, Liberty Global will own 100% of Ziggo
LBTYK: 46.05 (-0.18), LBTYB: 46.83 (+0.25), LBTYA: 47.50 (+0.10)

Will Economic Woes Hurt Liberty Global's (LBTYA) Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:50PM CST
Liberty Global, a leading cable MSO (multi service operator) in Europe, is scheduled to release its third-quarter 2014 financial numbers on Nov 5, after market close.
DRWI: 1.01 (-0.01), LBTYA: 47.50 (+0.10), LMOS: 16.92 (+0.15), BBRY: 11.57 (+0.30)

Liberty Global Schedules Investor Call for Third Quarter Results
Business Wire - Thu Oct 30, 3:15PM CDT
Liberty Global plc ("Liberty Global" or the "Company" (NASDAQ: LBTYA, LBTYB and LBTYK) today announced plans to release its third quarter 2014 results on Wednesday, November 5, 2014. You are invited to participate in Liberty Global's Investor Call, which will begin at 9:00 a.m. (Eastern Time), on Thursday, November 6, 2014. At that time, management will discuss the Company's results and business and expects to comment on the Company's outlook and provide other forward-looking information. Please call at least 15 minutes prior to the start of the teleconference.
LBTYK: 46.05 (-0.18), LBTYB: 46.83 (+0.25), LBTYA: 47.50 (+0.10)

Cable and Satellite Stocks Review - DIRECTV, Liberty Global, Time Warner Cable, Cablevision Systems, and DISH Network
PR Newswire - Thu Oct 30, 8:00AM CDT
Investor-Edge has initiated coverage on the following equities: DIRECTV (NASDAQ: DTV), Liberty Global PLC (NASDAQ: LBTYA), Time Warner Cable Inc. (NYSE: TWC), Cablevision Systems Corporation (NYSE: CVC), and DISH Network Corporation (NASDAQ: DISH). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, October 29, 2014, ended on a negative note as the Dow Jones Industrial Average finished at 16,974.31, down 0.18% and the NASDAQ Composite closed at 4,549.23, down 0.33%. The S&P 500 finished the session 0.14% lower at 1,982.30. During the trading session, seven out of ten sectors finished on a lower note. The S&P 500 Consumer Discretionary Sector Index ended the day at 531.19, down 0.33%, whereas the index has advanced 0.37% in the previous three months. Register for your complimentary reports on these five stocks at:
LBTYK: 46.05 (-0.18), LBTYA: 47.50 (+0.10), DTV: 87.67 (+0.29), TWC: 141.05 (+4.57), DISH: 64.53 (+0.71), CVC: 18.29 (+0.14)

AMC Networks is no Zombie Amid Cross-border Content Deals
at The Street - Fri Oct 24, 11:17AM CDT
Producer of The Walking Dead and Breaking Bad invests $200 million for a 49.9% stake in BBC America.
LBTYA: 47.50 (+0.10), AMCX: 60.65 (-0.75)

Global pay-TV subscriber growth still very much alive
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 10:30AM CDT

T: 35.70 (+0.30), AMX: 23.04 (+0.19), CHA: 64.65 (+1.15), LBTYA: 47.50 (+0.10), DTV: 87.67 (+0.29), TWC: 141.05 (+4.57), DISH: 64.53 (+0.71)

Liberty Global Announces Plan to Establish Tracking Stock for its Latin American Operations
Business Wire - Wed Oct 22, 3:40PM CDT
--Will create "pure-play" European and Latin American equities
LBTYK: 46.05 (-0.18), LBTYB: 46.83 (+0.25), LBTYA: 47.50 (+0.10)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 127

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 184

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 342

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 342

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading